Bio Protocol vs Saros — how do they compare? Bio Protocol trades at Rp434.72 (market cap Rp986,63M, Rp162,5M 24h volume), while Saros trades at Rp6.26 (market cap Rp24,09M, Rp10,4M 24h volume). The key difference: Bio Protocol is far larger — about 41× Saros's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 3,7B / 10B SAROS (38%) for Saros. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Saros for 23 Days on average.
| BIO | SAROS | |
|---|---|---|
Market Cap | Rp986,63M | Rp24,09M |
Volume (24h) | Rp162,5M | Rp10,4M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 3,7B / 10B SAROS (38%) |
Typical Hold Time | 18 Days | 23 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Saros presents as a micro-cap cryptocurrency with a market cap of Rp24.09M and limited circulating supply of 3.7M tokens. The asset shows minimal market activity with low trading volumes and limited exchange presence. Current technical indicators suggest extremely low liquidity and high volatility risk given the small market size.
Overall outlook remains highly speculative with major risks including liquidity constraints and limited adoption. Key opportunity lies in potential ecosystem growth, but investors should be aware of extreme volatility and the project's early-stage development status.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Saros is a digital identity platform and super app on the Solana blockchain. It started with the SarosSwap decentralized exchange and has grown into a full Web3 ecosystem. Its non-custodial wallet features Social Login, Watch-only mode, and an NFC hybrid wallet for better security and convenience. The wallet integrates with SolanaPay, facilitating efficient transactions through an in-house payment module.
Read more on SAROS →